National Pharmaceutical Council Inc
National Pharmaceutical Council Inc. maintains stable finances with consistent revenue and assets, but functional expense details are not provided.
EIN: 131772100 · Washington, DC · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $14.1M |
| Total Expenses | $9.1M |
| Program Spending | 75% |
| CEO/Top Officer Pay | $10 |
| Net Assets | $18.6M |
| Transparency Score | 70/100 |
Is National Pharmaceutical Council Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
National Pharmaceutical Council Inc directs 75% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About National Pharmaceutical Council Inc
National Pharmaceutical Council Inc (EIN: 131772100) is a nonprofit organization based in Washington, DC. The organization reported total revenue of $14.1M and total assets of $24.0M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of National Pharmaceutical Council Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
National Pharmaceutical Council Inc is a large nonprofit that has been operating for 71 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 2.9%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $11.0M |
| Total Expenses | $9.1M |
| Surplus / Deficit | +$1.9M |
| Total Assets | $23.4M |
| Total Liabilities | $4.8M |
| Net Assets | $18.6M |
| Operating Margin | 16.9% |
| Debt-to-Asset Ratio | 20.4% |
| Months of Reserves | 30.9 months |
Financial Health Grade: A
In 2023, National Pharmaceutical Council Inc reported a surplus of $1.9M with revenue exceeding expenses, holds 30.9 months of operating reserves (strong position), has a debt-to-asset ratio of 20.4% (moderate leverage).
Financial Trends
Over 13 years of filings (2011–2023), National Pharmaceutical Council Inc's revenue has grown at a compound annual growth rate (CAGR) of 2.9%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +32.2% | -9.9% | -4.9% |
| 2022 | -28.1% | -1.1% | -0.8% |
| 2021 | +1.1% | +7.0% | -4.1% |
| 2020 | +4.6% | +14.8% | +32.3% |
| 2019 | +16.6% | -11.1% | +1.5% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 1955 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates National Pharmaceutical Council Inc with a Mission Score of 70 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 75%
- fundraising: 10%
According to IRS 990 filings, National Pharmaceutical Council Inc allocates its expenses as follows: admin: 15%, programs: 75%, fundraising: 10%. With 75% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $1.9M, with revenue exceeding expenses.
- Debt-to-asset ratio: 20.4%.
Executive Compensation Analysis
The provided data consistently reports 0% officer compensation across all filings. This suggests that either executive compensation is not categorized under 'officer compensation' in these summaries, or it is minimal and covered by other expense lines, or the organization operates with uncompensated officers, which is uncommon for an entity with over $10 million in annual revenue.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of National Pharmaceutical Council Inc's IRS 990 filings:
- Lack of detailed functional expense breakdown in provided data
- Consistent 0% officer compensation reported, which may obscure actual executive pay without further detail
Strengths
The following positive indicators were identified for National Pharmaceutical Council Inc:
- Consistent revenue generation over the past decade
- Strong and stable asset base, consistently above $17 million and reaching $24 million in 2023
- Generally positive net income, indicating financial sustainability (e.g., $1.85M surplus in 2023)
Frequently Asked Questions about National Pharmaceutical Council Inc
Is National Pharmaceutical Council Inc a legitimate charity?
National Pharmaceutical Council Inc (EIN: 131772100) is a registered tax-exempt nonprofit based in Washington DC. Our AI analysis gives it a Mission Score of 70/100. It has 13 years of IRS 990 filings on record. Total revenue: $14.1M. 2 red flags identified. 3 strengths noted. Financial health grade: A.
How does National Pharmaceutical Council Inc spend its money?
National Pharmaceutical Council Inc directs 75% of its spending to programs and services. Fundraising costs 10%. This exceeds the 65% industry benchmark.
Are donations to National Pharmaceutical Council Inc tax-deductible?
National Pharmaceutical Council Inc is registered as a tax-exempt nonprofit (EIN: 131772100). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the National Pharmaceutical Council Inc CEO make?
National Pharmaceutical Council Inc's highest-compensated officer earns $10 annually. The organization reported $14.1M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of National Pharmaceutical Council Inc's spending goes to programs?
National Pharmaceutical Council Inc directs 75% to programs, 10% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
Where is National Pharmaceutical Council Inc located?
National Pharmaceutical Council Inc is headquartered in Washington, Washington DC and files with the IRS under EIN 131772100.
How many years of IRS 990 filings does National Pharmaceutical Council Inc have?
National Pharmaceutical Council Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $14.1M in total revenue.
Is National Pharmaceutical Council Inc. a good charity?
Based on the available financial data, the organization appears financially stable with a healthy asset base and generally positive net income. However, without a detailed breakdown of functional expenses (program, administrative, fundraising) and clarity on executive compensation, a comprehensive assessment of its charitable effectiveness and spending efficiency is limited.
How does National Pharmaceutical Council Inc. manage its executive compensation?
The provided IRS 990 data consistently shows 0% officer compensation. This indicates that either executive compensation is not reported under this specific line item in the summary, or it is covered by other expense categories, or the organization's officers are uncompensated. Further investigation into the full 990 forms would be needed for clarity.
What is the trend in National Pharmaceutical Council Inc.'s revenue and expenses?
Over the past decade, National Pharmaceutical Council Inc. has shown consistent revenue generation, generally ranging from $8 million to $11 million annually. Expenses have largely tracked revenue, with some years showing a slight deficit (e.g., 2022: Revenue $8.28M, Expenses $10.10M) and others a surplus (e.g., 2023: Revenue $10.95M, Expenses $9.10M). Overall, the organization maintains a stable financial trajectory.
Filing History
IRS 990 filing history for National Pharmaceutical Council Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), National Pharmaceutical Council Inc's revenue has grown by 41.1%, moving from $7.8M to $11.0M. Total assets increased by 25.2% over the same period, from $18.7M to $23.4M. Total functional expenses fell by 10.3%, from $10.1M to $9.1M. In its most recent filing year (2023), National Pharmaceutical Council Inc reported a surplus of $1.9M, with revenue exceeding expenses. The organization holds $4.8M in liabilities against $23.4M in assets (debt-to-asset ratio: 20.4%), resulting in net assets of $18.6M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $11.0M | $9.1M | $23.4M | $4.8M | — | — |
| 2022 | $8.3M | $10.1M | $24.6M | $8.0M | — | View 990 |
| 2021 | $11.5M | $10.2M | $24.8M | $6.0M | — | View 990 |
| 2020 | $11.4M | $9.5M | $25.9M | $8.4M | — | — |
| 2019 | $10.9M | $8.3M | $19.6M | $4.0M | — | View 990 |
| 2018 | $9.3M | $9.3M | $19.3M | $6.4M | — | View 990 |
| 2017 | $9.5M | $8.5M | $17.5M | $4.3M | — | View 990 |
| 2016 | $8.5M | $8.8M | $18.8M | $6.7M | — | View 990 |
| 2015 | $8.5M | $8.4M | $19.2M | $7.0M | — | View 990 |
| 2014 | $8.9M | $10.3M | $19.7M | $7.3M | — | View 990 |
| 2013 | $8.1M | $5.8M | $20.0M | $6.1M | — | View 990 |
| 2012 | $6.8M | $7.8M | $19.3M | $8.1M | — | View 990 |
| 2011 | $7.8M | $10.1M | $18.7M | $6.9M | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $11.0M, expenses of $9.1M, and assets of $23.4M (revenue +32.2% year-over-year).
- 2022: Revenue of $8.3M, expenses of $10.1M, and assets of $24.6M (revenue -28.1% year-over-year).
- 2021: Revenue of $11.5M, expenses of $10.2M, and assets of $24.8M (revenue +1.1% year-over-year).
- 2020: Revenue of $11.4M, expenses of $9.5M, and assets of $25.9M (revenue +4.6% year-over-year).
- 2019: Revenue of $10.9M, expenses of $8.3M, and assets of $19.6M (revenue +16.6% year-over-year).
- 2018: Revenue of $9.3M, expenses of $9.3M, and assets of $19.3M (revenue -1.6% year-over-year).
- 2017: Revenue of $9.5M, expenses of $8.5M, and assets of $17.5M (revenue +11.5% year-over-year).
- 2016: Revenue of $8.5M, expenses of $8.8M, and assets of $18.8M (revenue -0.4% year-over-year).
- 2015: Revenue of $8.5M, expenses of $8.4M, and assets of $19.2M (revenue -4.5% year-over-year).
- 2014: Revenue of $8.9M, expenses of $10.3M, and assets of $19.7M (revenue +10.0% year-over-year).
- 2013: Revenue of $8.1M, expenses of $5.8M, and assets of $20.0M (revenue +19.6% year-over-year).
- 2012: Revenue of $6.8M, expenses of $7.8M, and assets of $19.3M (revenue -12.5% year-over-year).
- 2011: Revenue of $7.8M, expenses of $10.1M, and assets of $18.7M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for National Pharmaceutical Council Inc:
Data Sources and Methodology
This transparency report for National Pharmaceutical Council Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.